Vivo Bio Tech Ltd Share Price (511509)

Vivo Bio Tech is a full service CRO that provides a range of drug development and discovery services tailored to the needs of global pharmaceutical and biotechnology companies in accordance with OECD AAALAC IND guidelines. With experienced and talented scientists, our services include In vitro and In vivo toxicity studies, pharmacological investigations, pharmacokinetics, toxicokinetic studies, gene synthesis, cloning, expression and purification of recombinant proteins and monoclonal antibodies. Additionally, we offer services for pharmacologic, toxicological and bioanalytical investigations for drug discovery and development, including bacterial reverse mutation assays, chromosomal aberration and micronucleus. Our Invivo Services group provides both nonregulatory and regulatory IND enabling preclinical development services as well as design and development of xenograft models for evaluation of anticancer agents. We have also partnered with Taconic for sourcing foundation and expansion colonies of animal models, in addition to beginning in-house breeding of Specific Pathogen Free rodents.

Share Price: ₹45.70 per share as on 19 Apr, 2024 04:01 PM
Market Capitalisation: ₹67.04Cr as of today
Revenue: ₹12.85Cr as on December 2023 (Q4 23)
Net Profit: ₹1.32Cr as on December 2023 (Q4 23)
Listing date: 01 Jan, 0001
Chairperson Name: K Sunder